title: Small cell lung cancer.
abstract: Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted.
authors: Gregory P
authors: GP
authors: Kalemkerian
authors: Wallace
authors: W
authors: Akerley
authors: Paul
authors: P
authors: Bogner
authors: Hossein
authors: H
authors: Borghaei
authors: Laura Qm
authors: LQ
authors: Chow
authors: Robert J
authors: RJ
authors: Downey
authors: Leena
authors: L
authors: Gandhi
authors: Apar Kishor P
authors: AK
authors: Ganti
authors: Ramaswamy
authors: R
authors: Govindan
authors: John C
authors: JC
authors: Grecula
authors: James
authors: J
authors: Hayman
authors: Rebecca Suk
authors: RS
authors: Heist
authors: Leora
authors: L
authors: Horn
authors: Thierry
authors: T
authors: Jahan
authors: Marianna
authors: M
authors: Koczywas
authors: Billy W
authors: BW
authors: Loo
authors: Robert E
authors: RE
authors: Merritt
authors: Cesar A
authors: CA
authors: Moran
authors: Harvey B
authors: HB
authors: Niell
authors: Janis
authors: J
authors: O'Malley
authors: Jyoti D
authors: JD
authors: Patel
authors: Neal
authors: N
authors: Ready
authors: Charles M
authors: CM
authors: Rudin
authors: Charles C
authors: CC
authors: Williams
authors: Kristina
authors: K
authors: Gregory
authors: Miranda
authors: M
authors: Hughes
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000517:prevention & control / Q000532:radiotherapy / Q000556:secondary*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy*; D009367:Neoplasm Staging; D011878:Radiotherapy; D055752:Small Cell Lung Carcinoma / Q000556:secondary* / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents